Shares of Scancell Holdings plc (LON:SCLP - Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 10.08 ($0.14) and traded as low as GBX 9.50 ($0.13). Scancell shares last traded at GBX 10 ($0.13), with a volume of 160,390 shares.
Scancell Stock Up 8.9%
The company has a 50 day moving average price of GBX 9.57 and a two-hundred day moving average price of GBX 10.06. The company has a debt-to-equity ratio of -566.79, a current ratio of 3.42 and a quick ratio of 13.01. The stock has a market cap of £107.20 million, a PE ratio of -15.87 and a beta of 0.35.
Insiders Place Their Bets
In other Scancell news, insider Martin Diggle acquired 44,944 shares of the company's stock in a transaction dated Tuesday, May 20th. The stock was purchased at an average price of GBX 9 ($0.12) per share, with a total value of £4,044.96 ($5,442.63). Company insiders own 4.96% of the company's stock.
Scancell Company Profile
(
Get Free Report)
Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
See Also
Before you consider Scancell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.
While Scancell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
